Colantoni, Alessandra
Bucci, Tommaso
Cocomello, Nicholas
Angelico, Francesco
Ettorre, Evaristo
Pastori, Daniele
Lip, Gregory Y.H.
Del Ben, Maria
Baratta, Francesco
Article History
Received: 5 March 2024
Accepted: 3 May 2024
First Online: 20 May 2024
Declarations
:
: Written consent was obtained from all subjects before the study, according to the ethical guidelines of the Declaration of Helsinki. The Ethics Committee of the Policlinic Umberto I Hospital of Rome (ref. n_2277/2011) approved the study.
: Gregory Y.H. Lip is a consultant and speaker for Bristol-Meyers Squibb/Pfizer, Boehringer Ingelheim, Anthos and Daiichi-Sankyo; no fees are received perÂsonally. Gregory Y.H. Lip is a National Institute for Health and Care Research Senior Investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 899871. The remaining authors have no disclosures to report.